BCR and prostate carcinoma: Taking into consideration the relatively increasing abundance of the seven selected proteins across the grade groups, their increased levels in BCR+ compared to BCR- and the available research on their involvement in (prostate) cancer, it is suggested that the selected proteins are promising candidates for further investigation as potential PCa aggressiveness markers.